Ignite Creation Date:
2024-05-06 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04714697
Status:
NOT_YET_RECRUITING
Last Update Posted:
2021-01-19
First Post:
2021-01-07
Brief Title:
Cabozantinib as Subsequent Therapy to an Immune Checkpoint Based Therapy in Renal Cell Carcinoma
Sponsor:
Organization:
Asan Medical Center